The Covid-19 Booster Has a Public Relations Problem
Related articles
More stories from COVID-19 Vaccines
New study shows effectiveness of COVID-19 booster
ABC News chief medical correspondent Dr. Jen Ashton breaks down a new study by the CDC on the booster shot’s effectiveness.
Expert talks about the new development in the COVID-19 vaccine
FOX6 News interviews Bill Hartman about the FDA's COVID-19 vaccine meeting.
Associated Pressflipped into PoliticsS. Dakota Senate suspends lawmaker after vaccine exchange
PIERRE, S.D. (AP) — The South Dakota Senate on Thursday suspended a Republican state senator in a rare move that stripped the lawmaker of all legislative power while keeping the allegations against her a secret. Sen. Julie Frye-Mueller, who is among a group of right-wing Statehouse Republicans, told …
Auto World Magflipped into Auto World3 of the Fastest-Growing Stocks on the Planet in 2023
There's little doubt that 2022 was a trying year for the vast majority of the investing community. All three major U.S. stock indexes fell into a …
More stories from Paul Offit
Grenadierflipped into A Todos LocosFDA Vaccine Advisory Committee member says it is time to rethink COVID-19 boosters
Dr. Paul Offit says not everyone should run out to get the latest booster shot.
BioPharma Diveflipped into BioPharma DiveFDA advisers back agency plan to simplify COVID-19 vaccination
A group of advisers to the Food and Drug Administration on Thursday backed the agency’s plan to simplify COVID-19 vaccine regimens, recommending that …
Were bivalent boosters worth it?
In early September, the Centers for Disease Control and Prevention (CDC) recommended updated Covid-19 boosters for all Americans 12 and over. The “update” was a broadening of the vaccines’ target: In addition to aiming for the initial strain of the virus, the new boosters would also take aim at the …
The future of covid vaccines: Four big questions for the FDA as it considers a move to annual shots
The agency’s vaccine advisers will vote on the plan on Thursday. The Food and Drug Administration is considering a plan that would shift covid …
